A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
11/2004
11/04/2004	WO2002072030A8 High affinity integrin polypeptides and uses thereof
11/04/2004	US20040220619 Method of inhibiting the proliferation of vascular smooth muscle cells
11/04/2004	US20040220411 Oxalic acid derivatives
11/04/2004	US20040220402 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
11/04/2004	US20040220260 efficacious in producing nitric oxide in the skin, the mucous membranes or the scalp; treatment of psoriasis lesions and/or chronic ulcers; i.e. Ascorbyl 2-O-cinnamate
11/04/2004	US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004	US20040220241 Substituted biphenyl derivatives
11/04/2004	US20040220230 transfroming growth factor antagonist; therapy for urogenital disorders, cardiovascular disorders
11/04/2004	US20040220223 Novel human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220200 Compositions useful as protein kinase inhibitors
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004	US20040220186 phosphodiesterase inhibitors
11/04/2004	US20040220175 (Pyrido/thieno) - [f] - oxazepine-5-one derivatives
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220147 Antiarrhythmia agents; liver disorders; skin disorders
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220131 administering an oligonucleotide antibody to reduce concentration of clustenin
11/04/2004	US20040220116 mixture with polysorbate; beverages, cosmetics, nutrient adjuvants, cleaning compounds,
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219635 Degradation resistant antihypoxic agents for use in treatment and prevention of hypoxia and ischemic related tissue damage
11/04/2004	US20040219233 the crude plant extract solvent extracted with a polar or nonpolar solvent; neurodegenerative diseaes, Alzheimer's and Parkinson's diseases, strokes; health foods, powders, tablets, capsules or beverages
11/04/2004	US20040219224 Spherical protein particles and methods for making and using them
11/04/2004	US20040219208 Sustained-release medicines
11/04/2004	US20040219207 Drug preparation comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219147 administering an anti-inflammatory compound, especially an antibody to a complement component or an NSAID, to a subject receiving a stent in connection with percutaneous transluminal coronary angioplasty.
11/04/2004	CA2522810A1 4-(4-trans-hydroxycyclohexyl)amino-2-phenyl-7h-pyrrolo[2,3d]pyrimidine hydrogen mesylate and its polymorphic forms
11/04/2004	CA2522756A1 Dihydrothiazine prodrugs of thiazolium agents
11/04/2004	CA2522536A1 Five-membered heterocyclic derivative
11/04/2004	CA2522300A1 Treatment of angiotensin ii related disease
11/04/2004	CA2520590A1 Substituted pyrroline kinase inhibitors
11/03/2004	EP1473304A1 Method for preparation of a N-terminally modified chemotactic factor
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1473288A1 Nitric ester derivatives of COX-2 inhibitors and their use for treating inflammation and cardiovascular diseases
11/03/2004	EP1473047A1 Microbial cellulose wound dressing, containing PHMB, for treating chronic wounds
11/03/2004	EP1473042A1 Controlling cholesterol catabolism via FXR receptor and screening for FXR receptor modulators
11/03/2004	EP1473032A1 Use of taurine, homotaurine and/or methionine for inducing analgesia or anesthesia
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472515A2 MINRs AS MODIFIERS FO INSULIN RECEPTOR SIGNALING AND METHODS OF USE
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472357A2 Elongase gene and method for producing polyunsaturated fatty acids
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472351A2 Amino acid sequences capable of facilitating penetration across a biological barrier
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472260A2 Thieno(3,2-b)pyridones as antiviral compounds
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472255A1 Aza-arylpiperazines
11/03/2004	EP1472251A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
11/03/2004	EP1472250A1 Anticholinergic agents, method for producing the same and use thereof as medicaments
11/03/2004	EP1472249A1 Xanthene-carboxylic acid esters of tropenol and scopine as m3 antagonists, method for producing the same and use thereof as medicaments
11/03/2004	EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472242A1 Zoniporide mesylate pharmaceutical compositions and processes for improving solubility of zoniporide
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472237A1 Catechol bioisosteres
11/03/2004	EP1472233A1 Pyrimidine compounds
11/03/2004	EP1472230A2 Ansamycins having improved pharmacological and biological properties
11/03/2004	EP1472228A1 Process for the manufacture of hmg-coa reductase inhibitors
11/03/2004	EP1472225A2 2-piperazine-pyridines useful for treating pain
11/03/2004	EP1472224A2 3-alkanoylamino-propionic acid derivatives used as inhibitors of integrin avss6
11/03/2004	EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
11/03/2004	EP1472215A2 (oxime)carbamoyl fatty acid amide hydrolase inhibitors
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1472021A2 Compositions including ammonia oxidizing bacteria and methods of using same
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471931A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/03/2004	EP1471930A1 Use of erythropoietin for the preventive or curative treatment of cardiac failure
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471910A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors
11/03/2004	EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004	EP1471905A1 Use of cholinesterase antagonists to treat insulin resistance
11/03/2004	EP1471901A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
11/03/2004	EP1471899A1 Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias
11/03/2004	EP1471886A1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use
11/03/2004	EP1471872A2 Treatment of colds and cough with a combination of a cyclooxygenase-2 selective inhibitor and a colds and cough active ingredient and compositions thereof
11/03/2004	EP1471871A2 Treatment of neurological dysfunction comprising fructopyranose sulfamates and erythropoietin
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1471849A2 Post-conditioning for the reduction of ischemic-reperfusion injury in the heart and other organs
11/03/2004	EP1435906A4 Method for producing biologically active products
11/03/2004	EP1377550B1 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/03/2004	EP1347974B1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
11/03/2004	EP1339716B1 lactam-substituted pyrazolopyridine derivatives
11/03/2004	EP1337271B1 Combination of gaba agonists and sorbitol dehydrogenase inhibitors
11/03/2004	EP1301504B1 Bifunctional agents possessing antioxidant and antiarrhythmic activity
11/03/2004	EP1289514B1 Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments

1 ... 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 ... 1595